Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000031.xml
Klin Monbl Augenheilkd 2015; 232(04): 593-594
DOI: 10.1055/s-0035-1545744
DOI: 10.1055/s-0035-1545744
Der interessante Fall
Bilateral Acute Iris Transillumination: A Rare Cause of Iris Atrophy. Report of 2 Cases
Bilaterale akute Iristransilluminationen. Eine seltene Ursache von Irisatrophie. Report von 2 FällenFurther Information
Publication History
Publication Date:
22 April 2015 (online)
Introduction
A new and rare syndrome named bilateral acute iris transillumination (BAIT) was recently described [1]. It is characterized by bilateral conjunctival injection, photophobia, atonic pupils with distorted margins and a diffuse iris transillumination. This syndrome is often associated with a history of flu-like symptoms and use of systemic fluoroquinolones and other antibiotics [1], [2]. We describe two patients who developed BAIT, but only one patient was treated with moxifloxacine for a sinusitis.
-
References
- 1 Tugal-Tutkun I, Onal S, Garip A et al. Bilateral acute iris transillumination. Arch Ophthalmol 2011; 129: 1312-1319
- 2 Hinkle DM, Dacey MS, Mandelcorn E et al. Bilateral uveitis associated with fluroquinolone therapy. Cutan Ocul Toxicol 2012; 31: 111-116
- 3 Siefert HM, Kohlsdorfer C, Steinke W et al. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats. J Antimicrob Chemother 1999; 43: 61-67
- 4 Hamanaka H, Mizutani H, Asahig K et al. Melanocyte melanin augments sparfloxacin-induced phototoxicity. J Dermatol Sci 1999; 21: 27-33
- 5 Fukuda M, Sasaki K. Different iris coloration and uptake of a fluoroquinolone agent into the iris ciliary body of rabbit eyes. Ophthalmic Res 1994; 26: 137-140
- 6 Knape RM, Sayyad FE, Davis JL. Moxifloxacin and bilateral acute iris transillumination. J Ophthalmic Inflamm Infect 2013; 3: 10
- 7 Morshedi RG, Bettis DI, Moshirfar M et al. Bilateral acute iris transillumination following systemic moxifloxacin for respiratory illness: report of two cases and review of the literature. Ocul Immunol Inflamm 2012; 20: 266-272
- 8 Bettink-Remeijer MW, Brouwers K, van Langenhover L et al. Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. Eye 2009; 23: 2260-2262
- 9 Willermain F, Deflorenne C, Bouffioux C et al. Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. Eye 2010; 24: 1419D